Living Cell Technologies Limited

ASX:LCT ISIN:AU000000LCT6

Living Cell Technologies Ltd (LCT) is an advanced biotechnology company currently listed on the Australian Stock Exchange. LCT’s focus is on market-driven encapsulated living cell products, for the treatment of Huntington's disease, haemophilia and insulin-dependent diabetes. LCT’s business was formed in 1987 to research cell extraction and to develop procedures for advanced living-cell replacement therapies.

查看其它語言版本

新聞

2010年12月31日澳洲股市：Moly Mines (ASX:MOL)向中國船運首批鐵礦石

🕔12/31/2010 11:30:00 AM 10357

2010年12月31日澳洲股市報告包括：Moly Mines (ASX:MOL)首批54,500噸鐵礦石已發往中國；Living Cell Technologies Limited (ASX:LCT)宣布籌資5,750,000澳元；OM Holdings Limited (ASX:OMH)拿到興建馬來西亞燒結和熔煉廠所需地塊；Perilya Limited (ASX:PEM)提高Broken Hill項目礦產資源量和礦石儲量。

閱讀全文▸

2010年8月4日澳洲股市

🕔8/4/2010 1:31:47 PM 12574

澳洲股市前一天觸及六周高點後，週三開盤下挫，回吐出先前漲幅。 S&P/ASX200指數早盤下挫0.3%，報4558.1點, 綜合指數下跌0.28%, 報4573.8點。金融股和工業股下跌0.5%，材料股下挫0.4%。